← Back to guidelines
Cardiology59 papers

Invasive Streptococcus pneumoniae disease

Last edited: 4/23/2026

Overview

Invasive Streptococcus pneumoniae disease refers to infections caused by Streptococcus pneumoniae bacteria that penetrate deeper tissues or organs, leading to severe conditions such as bacteremia, meningitis, and pneumonia 1.

Diagnosis

  • Clinical Presentation: Symptoms vary by site of infection (e.g., fever, sepsis, focal signs).
  • Laboratory Tests: Blood cultures are essential for diagnosis 1.
  • Imaging: Chest X-ray or CT for pneumonia, lumbar puncture for meningitis 1.
  • Antigen Testing: Rapid antigen detection tests can be useful but have variable sensitivity 1.
  • PCR: Polymerase chain reaction for nucleic acid detection in cerebrospinal fluid or blood 1.
  • Serotyping: Recommended for epidemiological purposes and guiding antibiotic therapy 1.
  • Management

  • First-Line Antibiotics:
  • - Penicillin G: 200,000 units/kg/dose IV every 4 hours for severe infections (Evidence: Strong) 1. - Ceftriaxone: 80-100 mg/kg/day IV for non-penicillin-sensitive strains (Evidence: Strong) 1.
  • Adjunctive Treatments:
  • - Corticosteroids: Consider in meningitis to reduce inflammation and improve outcomes (Evidence: Moderate) 1. - Supportive Care: Includes fluid management, ventilation, and management of complications (Evidence: Expert opinion) 1.

    Special Populations

  • Pediatrics: Similar management principles apply, with careful monitoring of dosing and renal function (Evidence: Expert opinion) 1.
  • Elderly: Increased vigilance for complications and comorbidities; tailored supportive care (Evidence: Expert opinion) 1.
  • Comorbidities: Patients with underlying conditions like COPD or immunocompromise may require extended antibiotic courses (Evidence: Expert opinion) 1.
  • Key Recommendations

  • Initiate Blood Cultures immediately in suspected cases to confirm diagnosis (Evidence: Strong) 1.
  • Use Penicillin G as first-line therapy for susceptible strains (Evidence: Strong) 1.
  • Consider Corticosteroids in patients with pneumococcal meningitis to reduce morbidity (Evidence: Moderate) 1.
  • Tailor Management based on patient-specific factors such as age and comorbidities (Evidence: Expert opinion) 1.
  • References

    1 Weinstein MR, Litt M, Kertesz DA, Wyper P, Rose D, Coulter M et al.. Invasive infections due to a fish pathogen, Streptococcus iniae. S. iniae Study Group. The New England journal of medicine 1997. link

    Original source

    1. [1]
      Invasive infections due to a fish pathogen, Streptococcus iniae. S. iniae Study Group.Weinstein MR, Litt M, Kertesz DA, Wyper P, Rose D, Coulter M et al. The New England journal of medicine (1997)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG